Aprea Therapeutics (APRE) Current Leases (2019 - 2022)
Aprea Therapeutics (APRE) posted quarterly Current Leases of $110551.0 for Q3 2022, down 50.65% year-over-year from $223999.0 in Q3 2021, and down 41.54% quarter-over-quarter from $189116.0 in Q2 2022.
Aprea Therapeutics (APRE) Current Leases (2019 - 2022) Analysis & Trends
Aprea Therapeutics (APRE) has reported Current Leases for 4 consecutive years, with $110551.0 the latest figure, recorded in Q3 2022.
- In Q3 2022, Current Leases fell 50.65% year-over-year to $110551.0; the TTM figure through Sep 2022 stood at $110551.0 (down 50.65% YoY), while the FY2021 annual figure was $190471.0, down 25.69% from the prior year.
- Current Leases slipped to $110551.0 in Q3 2022 per APRE's latest filing, from $189116.0 in the prior quarter.
- Across five years, Current Leases topped out at $256309.0 in Q4 2020 and bottomed at $110551.0 in Q3 2022.
- Historically, Current Leases has averaged $216037.7 across 4 years, with a median of $225537.0 in 2021.
- Annual changes were most pronounced in 2020 — Current Leases grew 7.7% — and 2022, when it tumbled 50.65%.
- Aprea Therapeutics' Current Leases stood at $242329.0 in 2019, then gained by 5.77% to $256309.0 in 2020, then slipped by 25.69% to $190471.0 in 2021, then sank by 41.96% to $110551.0 in 2022.
- Business Quant data shows APRE's Current Leases at $110551.0 in Q3 2022, $189116.0 in Q2 2022, and $219499.0 in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 45.93 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 6.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | Aprea Therapeutics | 34.28 Mn | 34.28 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 110,551.00 |
| Jun 30, 2022 | 189,116.00 |
| Mar 31, 2022 | 219,499.00 |
| Dec 31, 2021 | 190,471.00 |
| Sep 30, 2021 | 223,999.00 |
| Jun 30, 2021 | 199,219.00 |
| Mar 31, 2021 | 225,537.00 |
| Dec 31, 2020 | 256,309.00 |
| Sep 30, 2020 | 244,310.00 |
| Jun 30, 2020 | 241,527.00 |
| Mar 31, 2020 | 238,771.00 |
| Dec 31, 2019 | 242,329.00 |
| Sep 30, 2019 | 226,852.00 |